Case study of semaglutide and cardiovascular outcomes: An application of the C<i>ausal Roadmap</i> to a hybrid design for augmenting an RCT control arm with real-world data.

Dang, Lauren E; Fong, Edwin; Tarp, Jens Magelund; Clemmensen, Kim Katrine Bjerring; Ravn, Henrik; Kvist, Kajsa; Buse, John B; van der Laan, Mark; Petersen, Maya

Case study of semaglutide and cardiovascular outcomes: An application of the Causal Roadmap to a hybrid design for augmenting an RCT control arm with real-world data.

Dang, Lauren E; Fong, Edwin; Tarp, Jens Magelund; Clemmensen, Kim Katrine Bjerring; Ravn, Henrik; Kvist, Kajsa; Buse, John B; van der Laan, Mark; Petersen, Maya.

Afiliação

Dang LE; Department of Biostatistics, University of California, Berkeley, CA, USA.
Fong E; Novo Nordisk, Søborg, Denmark.
Tarp JM; Novo Nordisk, Søborg, Denmark.
Clemmensen KKB; Novo Nordisk, Søborg, Denmark.
Ravn H; Novo Nordisk, Søborg, Denmark.
Kvist K; Novo Nordisk, Søborg, Denmark.
Buse JB; Division of Endocrinology, Department of Medicine, University of North Carolina, Chapel Hill, NC, USA.
van der Laan M; Department of Biostatistics, University of California, Berkeley, CA, USA.
Petersen M; Department of Biostatistics, University of California, Berkeley, CA, USA.

J Clin Transl Sci ; 7(1): e231, 2023.

Article em En | MEDLINE | ID: mdl-38028337

Palavras-chave

Causal inference; cardiovascular outcomes; diabetes; hybrid study designs; real-world evidence

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Idioma: En Revista: J Clin Transl Sci Ano de publicação: 2023 Tipo de documento: Article País de afiliação: Estados Unidos

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google